Problematic Pharmaceutical Opioid Use Common in Noncancer Pain
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 15, 2024 -- For individuals with chronic noncancer pain (CNCP) treated with opioid analgesics, problematic pharmaceutical opioid use (POU) is common, according to a study published online Aug. 7 in Addiction.
Kyla H. Thomas, Ph.D., M.B.B.S., from the University of Bristol in the United Kingdom, and colleagues conducted a comprehensive systematic literature review and meta-analysis to examine the prevalence of POU in CNCP patients (aged 12 years and older) treated with opioid analgesics. POU was defined as dependence and opioid use disorder (D&OUD), signs and symptoms of D&OUD (S&S), aberrant behavior (AB), and at risk for D&OUD. Data were included from 148 studies with more than 4.3 million participants; 1 percent of studies had a high risk for bias.
The researchers found that the pooled prevalence was 9.3 percent (I2, 99.9 percent), 29.6 percent (I2, 99.3 percent), and 22 percent (I2, 99.8 percent) for D&OUD, S&S, and AB, respectively, while prevalence of those at risk for D&OUD was 12.4 percent (I2, 99.6 percent). Study setting, study design, and diagnostic tool affected prevalence. The findings should be interpreted with caution due to high heterogeneity, according to the researchers.
"Clinicians and policymakers need a more accurate estimate of the prevalence of problematic opioid use in pain patients so that they can gauge the true extent of the problem, change prescribing guidance if necessary, and develop and implement effective interventions to manage the problem," Thomas said in a statement. "Knowing the size of the problem is a necessary step to managing it."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Previous Estimates of Illicit Opioid Use in the United States Underreported
WEDNESDAY, May 14, 2025 -- Illicit opioid use may be higher than previously reported in the United States, according to a study published online May 9 in JAMA Health...
Rates of Fentanyl Nonfatal Overdose ED Visits Rose Through Third Quarter of 2023
WEDNESDAY, May 14, 2025 -- From 2020 to 2023, there was an increase in the rates of fentanyl-involved nonfatal overdose emergency department visits, according to research...
Nearly 19 Million Children Live Under Same Roof as Parent With Substance Use Disorder
TUESDAY, May 13, 2025 -- In 2023, nearly 19 million children in the United States were estimated to be living in a household with at least one parent or primary caregiver with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.